RespireRx Pharmaceuticals Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
RespireRx Pharmaceuticals Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2023.
  • RespireRx Pharmaceuticals Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$333K, a 14.5% increase year-over-year.
  • RespireRx Pharmaceuticals Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$1.41M, a 24.7% increase year-over-year.
  • RespireRx Pharmaceuticals Inc. annual Operating Income (Loss) for 2022 was -$1.58M, a 38.3% increase from 2021.
  • RespireRx Pharmaceuticals Inc. annual Operating Income (Loss) for 2021 was -$2.56M, a 22.8% increase from 2020.
  • RespireRx Pharmaceuticals Inc. annual Operating Income (Loss) for 2020 was -$3.32M, a 90.9% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$1.41M -$333K +$56.5K +14.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-17
Q2 2023 -$1.47M -$466K -$113K -32.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-21
Q1 2023 -$1.35M -$390K +$227K +36.7% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-22
Q4 2022 -$1.58M -$221K +$293K +57% Oct 1, 2022 Dec 31, 2022 10-K 2023-04-17
Q3 2022 -$1.87M -$389K +$192K +33.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-17
Q2 2022 -$2.06M -$352K +$312K +46.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
Q1 2022 -$2.38M -$617K +$183K +22.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 -$2.56M -$514K +$352K +40.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 -$2.91M -$581K +$731K +55.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-17
Q2 2021 -$3.64M -$664K -$47.1K -7.63% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-22
Q1 2021 -$3.59M -$800K -$280K -53.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 -$3.32M -$866K -$452K -109% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-15
Q3 2020 -$2.86M -$1.31M -$882K -205% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$1.98M -$617K -$199K -47.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$1.78M -$521K -$46.7K -9.86% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-24
Q4 2019 -$1.74M -$414K +$166K +28.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-15
Q3 2019 -$1.9M -$430K +$73.1K +14.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-23
Q2 2019 -$1.98M -$418K +$168K +28.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-19
Q1 2019 -$2.14M -$474K +$32.3K +6.38% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-20
Q4 2018 -$2.18M -$580K +$104K +15.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-14
Q3 2018 -$2.28M -$504K +$89.6K +15.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-19
Q2 2018 -$2.37M -$587K +$963K +62.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$3.33M -$506K +$915K +64.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
Q4 2017 -$4.25M -$684K +$772K +53% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-16
Q3 2017 -$5.02M -$593K +$1.66M +73.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-16
Q2 2017 -$6.68M -$1.55M +$800K +34.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-10-15
Q1 2017 -$7.48M -$1.42M +$996K +41.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q4 2016 -$8.47M -$1.46M +$105K +6.71% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-17
Q3 2016 -$8.58M -$2.25M -$227K -11.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-20
Q2 2016 -$8.35M -$2.35M -$1.29M -122% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$7.06M -$2.42M -$1.82M -305% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-19
Q4 2015 -$5.24M -$1.56M -$872K -127% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$4.37M -$2.02M -$1.06M -110% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-15
Q2 2015 -$3.31M -$1.06M -$773K -269% Apr 1, 2015 Jun 30, 2015 10-Q/A 2016-08-12
Q1 2015 -$2.54M -$596K +$1.82M +75.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$4.35M -$689K -$630K -1066% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-29
Q3 2014 -$3.72M -$965K -$906K -1553% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$2.82M -$288K -$108K -60.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$2.71M -$2.41M -$1.57M -186% Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-08-07
Q4 2013 -$1.14M -$59.1K +$3.7M +98.4% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-30
Q3 2013 -$4.84M -$58.3K +$1.61M +96.5% Jul 1, 2013 Sep 30, 2013 10-Q 2015-03-09
Q2 2013 -$6.45M -$179K +$793K +81.6% Apr 1, 2013 Jun 30, 2013 10-Q 2015-02-24
Q1 2013 -$7.24M -$843K +$91.1K +9.75% Jan 1, 2013 Mar 31, 2013 10-Q 2015-02-10
Q4 2012 -$7.33M -$3.76M -$4.59M -551% Oct 1, 2012 Dec 31, 2012 10-K 2015-01-06
Q3 2012 -$2.74M -$1.67M -$494K -42.1% Jul 1, 2012 Sep 30, 2012 10-Q 2014-12-15
Q2 2012 -$2.25M -$972K -$608K -167% Apr 1, 2012 Jun 30, 2012 10-Q 2014-12-15
Q1 2012 -$1.64M -$934K +$625K +40.1% Jan 1, 2012 Mar 31, 2012 10-Q 2014-11-24
Q4 2011 -$2.26M $833K Oct 1, 2011 Dec 31, 2011 10-K 2014-10-14
Q3 2011 -$1.17M -$641K -121% Jul 1, 2011 Sep 30, 2011 10-Q 2014-07-30
Q2 2011 -$364K +$1.61M +81.5% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-16
Q1 2011 -$1.56M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$531K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$1.97M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.